These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 10594856)

  • 1. Chemoradiation with or without intraoperative radiation therapy in patients with locally recurrent rectal carcinoma: prognostic factors and long term outcome.
    Valentini V; Morganti AG; De Franco A; Coco C; Ratto C; Battista Doglietto G; Trodella L; Ziccarelli L; Picciocchi A; Cellini N
    Cancer; 1999 Dec; 86(12):2612-24. PubMed ID: 10594856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined-modality therapy in locally advanced primary rectal cancer.
    Ratto C; Valentini V; Morganti AG; Barbaro B; Coco C; Sofo L; Balducci M; Gentile PC; Pacelli F; Doglietto GB; Picciocchi A; Cellini N
    Dis Colon Rectum; 2003 Jan; 46(1):59-67. PubMed ID: 12544523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients.
    Valentini V; Coco C; Picciocchi A; Morganti AG; Trodella L; Ciabattoni A; Cellini F; Barbaro B; Cogliandolo S; Nuzzo G; Doglietto GB; Ambesi-Impiombato F; Cosimelli M
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):664-74. PubMed ID: 12062610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T4 rectal cancer treated with preoperative chemoradiation to the posterior pelvis followed by multivisceral resection: patterns of failure and limitations of treatment.
    Sanfilippo NJ; Crane CH; Skibber J; Feig B; Abbruzzese JL; Curley S; Vauthey JN; Ellis LM; Hoff P; Wolff RA; Brown TD; Cleary K; Wong A; Phan T; Janjan NA
    Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):176-83. PubMed ID: 11516868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome.
    Pucciarelli S; Toppan P; Friso ML; Russo V; Pasetto L; Urso E; Marino F; Ambrosi A; Lise M
    Dis Colon Rectum; 2004 Nov; 47(11):1798-807. PubMed ID: 15622571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent 5-fluorouracil, mitomycin C and radiation, with or without brachytherapy, in recurrent endometrial cancer: a scoring system to predict clinical response and outcome.
    Smaniotto D; D'Agostino G; Luzi S; Valentini V; Macchia G; Mangiacotti MG; Margariti PA; Ferrandina G; Scambia G
    Tumori; 2005; 91(3):215-20. PubMed ID: 16206643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Locally recurrent rectal cancer: prognostic factors and long-term outcomes of multimodal therapy.
    Pacelli F; Tortorelli AP; Rosa F; Bossola M; Sanchez AM; Papa V; Valentini V; Doglietto GB
    Ann Surg Oncol; 2010 Jan; 17(1):152-62. PubMed ID: 19834766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase I/II study of irinotecan when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group Study.
    Glynne-Jones R; Falk S; Maughan TS; Meadows HM; Sebag-Montefiore D
    Br J Cancer; 2007 Feb; 96(4):551-8. PubMed ID: 17262086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraoperative irradiation after palliative surgery for locally recurrent rectal cancer.
    Suzuki K; Gunderson LL; Devine RM; Weaver AL; Dozois RR; Ilstrup DM; Martenson JA; O'Connell MJ
    Cancer; 1995 Feb; 75(4):939-52. PubMed ID: 7531113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcome of interstitial pulsed dose rate brachytherapy in multimodality treatment of locally advanced primary or recurrent rectal and sigmoid cancer with high risk of incomplete microscopic resection.
    Nielsen MB; Rasmussen PC; Tanderup K; Nielsen SK; Fokdal L; Laurberg S; Lindegaard JC
    Acta Oncol; 2016 Dec; 55(12):1408-1413. PubMed ID: 27537776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of postchemoradiation stage following preoperative chemotherapy and radiation for advanced/recurrent rectal cancers.
    Mohiuddin M; Hayne M; Regine WF; Hanna N; Hagihara PF; McGrath P; Marks GM
    Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1075-80. PubMed ID: 11072165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent 5-fluorouracil, mitomycin C and radiation with or without brachytherapy in recurrent cervical cancer: a scoring system to predict clinical response and outcome.
    Smaniotto D; D'Agostino G; Luzi S; Valentini V; Macchia G; Mantini G; Margariti PA; Ferrandina G; Scambia G
    Tumori; 2005; 91(4):295-301. PubMed ID: 16277092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative infusional chemoradiation and surgery with or without an electron beam intraoperative boost for advanced primary rectal cancer.
    Weinstein GD; Rich TA; Shumate CR; Skibber JM; Cleary KR; Ajani JA; Ota DM
    Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):197-204. PubMed ID: 7721616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High dose rate intraoperative radiation therapy (HDR-IORT) as part of the management strategy for locally advanced primary and recurrent rectal cancer.
    Harrison LB; Minsky BD; Enker WE; Mychalczak B; Guillem J; Paty PB; Anderson L; White C; Cohen AM
    Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):325-30. PubMed ID: 9788411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
    Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
    Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Sandwich" preoperative and postoperative combined chemotherapy and radiation in tethered and fixed rectal cancer: impact of treatment intensity on local control and survival.
    Chan AK; Wong AO; Langevin JM; Jenken DA; Khoo R; Heine JA; Buie WD; Johnson DR
    Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):629-37. PubMed ID: 9112462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective single-arm study of intraoperative radiotherapy for locally advanced or recurrent rectal cancer.
    Tan J; Heriot AG; Mackay J; Van Dyk S; Bressel MA; Fox CD; Hui AC; Lynch AC; Leong T; Ngan SY
    J Med Imaging Radiat Oncol; 2013 Oct; 57(5):617-25. PubMed ID: 24119279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative chemotherapy and pelvic radiation for tethered or fixed rectal cancer: a phase II dose escalation study.
    Chan AK; Wong AO; Langevin J; Jenken D; Heine J; Buie D; Johnson DR
    Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):843-56. PubMed ID: 11020583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant chemoradiation plus intraoperative radiotherapy versus adjuvant chemoradiation alone in patients with locally advanced rectal cancer.
    Zhang Q; Tey J; Yang Z; Li P; Peng L; Fu S; Huang G; Xiong F; Lu JJ
    Am J Clin Oncol; 2015 Feb; 38(1):11-6. PubMed ID: 25616201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.